Literature DB >> 7286044

Human plasma vasopressin response to potent loop-diuretic drugs.

P H Baylis, F C De Beer.   

Abstract

To investigate the effect of potent loop diuretic drugs on the factors that control water excretion, immunoreactive plasma arginine vasopressin was measured at regular intervals for 6 h after intravenous administration of frusemide (40 mg) and piretanide (12 mg) in healthy adults. Despite a large diuresis there was no significant rise in plasma vasopressin compared to controls. Diuretic drug treatment caused small increases in plasma osmolality comparable to the control group, but no change in mean arterial blood pressure. The fall in blood volume of 7% within 1 h of frusemide administration was insufficient to stimulate vasopressin secretion. We conclude that loop diuretic drugs in the dose given have little effect on plasma vasopressin and osmolality but cause a small fall in blood volume in healthy adults.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286044     DOI: 10.1007/BF00615403

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  The early effects of intravenous frusemide on central haemodynamics, venous tone and plasma renin activity.

Authors:  B Hesse; I Nielsen; H Lund-Jacobsen
Journal:  Clin Sci Mol Med       Date:  1975-12

2.  Stimulated renin: a screening test for hypertension.

Authors:  L Wallach; I Nyarai; K G Dawson
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

3.  The antidiuretic hormone and the factors which determine its release.

Authors:  E B VERNEY
Journal:  Proc R Soc Lond B Biol Sci       Date:  1947-12-16

4.  The osmoregulation of vasopressin.

Authors:  G L Robertson; R L Shelton; S Athar
Journal:  Kidney Int       Date:  1976-07       Impact factor: 10.612

5.  Influence of presyncope and postural change upon plasma arginine vasopressing concentration in hydrated and dehydrated man.

Authors:  P H Baylis; D A Heath
Journal:  Clin Endocrinol (Oxf)       Date:  1977-07       Impact factor: 3.478

6.  Effect of moderate hemorrhage in humans on plasma ADH and renin.

Authors:  K L Goetz; G C Bond; W E Smith
Journal:  Proc Soc Exp Biol Med       Date:  1974-01

Review 7.  The regulation of vasopressin function in health and disease.

Authors:  G L Robertson
Journal:  Recent Prog Horm Res       Date:  1976

8.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

9.  Endogenous angiotensin stimulation of vasopressin in the newborn lamb.

Authors:  S R Siegel; R E Weitzman; D A Fisher
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

10.  Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man.

Authors:  R Fraser; V H James; J J Brown; P Isaac; A F Lever; J I Robertson
Journal:  Lancet       Date:  1965-11-13       Impact factor: 79.321

View more
  4 in total

1.  Intravenous bumetanide attenuates the rise in plasma vasopressin concentrations during major surgical operations.

Authors:  L Kaufman; P M Bailey
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

2.  SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats.

Authors:  Takahiro Masuda; Ken Ohara; Volker Vallon; Daisuke Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-28

Review 3.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes.

Authors:  Angela Kim; Jakob G Knudsen; Joseph C Madara; Anna Benrick; Thomas G Hill; Lina Abdul Kadir; Joely A Kellard; Lisa Mellander; Caroline Miranda; Haopeng Lin; Timothy James; Kinga Suba; Aliya F Spigelman; Yanling Wu; Patrick E MacDonald; Ingrid Wernstedt Asterholm; Tore Magnussen; Mikkel Christensen; Tina Vilsbøll; Victoria Salem; Filip K Knop; Patrik Rorsman; Bradford B Lowell; Linford Jb Briant
Journal:  Elife       Date:  2021-11-17       Impact factor: 8.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.